Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eton Pharmaceuticals, Inc. | Chief Business Officer | Common Stock | 12.8K | $27K | $2.10 | Mar 1, 2023 | Direct |
Eton Pharmaceuticals, Inc. | Chief Business Officer | Stock Option (Right to buy) | 813K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ETON | Eton Pharmaceuticals, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | Chief Business Officer |
ETON | Eton Pharmaceuticals, Inc. | Mar 1, 2023 | 0 | $0 | 3 | Mar 8, 2023 | Chief Business Officer |